These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells. Seth S; Georgoudaki AM; Chambers BJ; Qiu Q; Kremmer E; Maier MK; Czeloth N; Ravens I; Foerster R; Bernhardt G J Leukoc Biol; 2009 Jul; 86(1):91-101. PubMed ID: 19380711 [TBL] [Abstract][Full Text] [Related]
6. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681 [TBL] [Abstract][Full Text] [Related]
7. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383 [TBL] [Abstract][Full Text] [Related]
8. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases. Chan CJ; Andrews DM; McLaughlin NM; Yagita H; Gilfillan S; Colonna M; Smyth MJ J Immunol; 2010 Jan; 184(2):902-11. PubMed ID: 20008292 [TBL] [Abstract][Full Text] [Related]
9. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Castriconi R; Dondero A; Corrias MV; Lanino E; Pende D; Moretta L; Bottino C; Moretta A Cancer Res; 2004 Dec; 64(24):9180-4. PubMed ID: 15604290 [TBL] [Abstract][Full Text] [Related]
10. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Tahara-Hanaoka S; Shibuya K; Kai H; Miyamoto A; Morikawa Y; Ohkochi N; Honda S; Shibuya A Blood; 2006 Feb; 107(4):1491-6. PubMed ID: 16249389 [TBL] [Abstract][Full Text] [Related]
11. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979 [TBL] [Abstract][Full Text] [Related]
12. Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226. Liu J; Qian X; Chen Z; Xu X; Gao F; Zhang S; Zhang R; Qi J; Gao GF; Yan J J Immunol; 2012 Jun; 188(11):5511-20. PubMed ID: 22547693 [TBL] [Abstract][Full Text] [Related]
13. DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders. Elishmereni M; Bachelet I; Levi-Schaffer F Curr Opin Investig Drugs; 2008 May; 9(5):491-6. PubMed ID: 18465659 [TBL] [Abstract][Full Text] [Related]
14. Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1. Okumura G; Abe F; Hirochika R; Shibuya A; Shibuya K Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):135-139. PubMed ID: 28498033 [TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a novel anti-DNAM-1 monoclonal antibody. Yamashita Y; Abe F; Hirochika R; Tahara-Hanaoka S; Shibuya A; Shibuya K Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):60-4. PubMed ID: 23600509 [TBL] [Abstract][Full Text] [Related]
16. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. Shibuya K; Shirakawa J; Kameyama T; Honda S; Tahara-Hanaoka S; Miyamoto A; Onodera M; Sumida T; Nakauchi H; Miyoshi H; Shibuya A J Exp Med; 2003 Dec; 198(12):1829-39. PubMed ID: 14676297 [TBL] [Abstract][Full Text] [Related]
17. The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens. Maier MK; Seth S; Czeloth N; Qiu Q; Ravens I; Kremmer E; Ebel M; Müller W; Pabst O; Förster R; Bernhardt G Eur J Immunol; 2007 Aug; 37(8):2214-25. PubMed ID: 17621371 [TBL] [Abstract][Full Text] [Related]
18. Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5. Wang H; Qi J; Zhang S; Li Y; Tan S; Gao GF Proc Natl Acad Sci U S A; 2019 Jan; 116(3):988-996. PubMed ID: 30591568 [TBL] [Abstract][Full Text] [Related]
19. LFA-1-dependent lipid raft recruitment of DNAM-1 (CD226) in CD4+ T cell. Shirakawa J; Wang Y; Tahara-Hanaoka S; Honda S; Shibuya K; Shibuya A Int Immunol; 2006 Jun; 18(6):951-7. PubMed ID: 16636013 [TBL] [Abstract][Full Text] [Related]
20. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Pende D; Castriconi R; Romagnani P; Spaggiari GM; Marcenaro S; Dondero A; Lazzeri E; Lasagni L; Martini S; Rivera P; Capobianco A; Moretta L; Moretta A; Bottino C Blood; 2006 Mar; 107(5):2030-6. PubMed ID: 16304049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]